ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,338,827,000 | -59.3% | 32,331 | -41.4% | 0.02% | -53.5% |
| Q2 2022 | $3,292,039,000 | -8.2% | 55,180 | +11.7% | 0.04% | +4.9% |
| Q1 2022 | $3,585,975,000 | -16.0% | 49,380 | -2.8% | 0.04% | -6.8% |
| Q4 2021 | $4,270,090,000 | -10.8% | 50,780 | -4.3% | 0.04% | -13.7% |
| Q3 2021 | $4,787,286,000 | +3.6% | 53,080 | +9.5% | 0.05% | +10.9% |
| Q2 2021 | $4,622,758,000 | -19.7% | 48,482 | -4.1% | 0.05% | -28.1% |
| Q1 2021 | $5,758,014,000 | -4.3% | 50,571 | +16.3% | 0.06% | -5.9% |
| Q4 2020 | $6,017,690,000 | +87.8% | 43,471 | +11.5% | 0.07% | +58.1% |
| Q3 2020 | $3,204,341,000 | +16.8% | 38,987 | +11.1% | 0.04% | +4.9% |
| Q2 2020 | $2,744,505,000 | – | 35,087 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |